Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Exosomal microRNAs as a promising theragnostic tool for essential hypertension

Hypertension Research volume 43, pages 74–75 (2020)Cite this article

Essential hypertension is one of the major modifiable risk factors contributing to the clinical manifestations of cardiovascular, cerebrovascular and renal diseases. The complexity of the disease is attributed to genetic, epigenetic and environmental components [1]. The prevalence of high blood pressure has recently shifted from high-middle-income countries to low-middle-income countries. This drift may be largely attributed to age, gender, lifestyle factors, race and ethnicity, and prevailing comorbid conditions in the population studied [2]. Despite the intense knowledge accumulated over the past several decades on the physiological pathways and genes associated with EH, several lacunae remain in hypertension genetics, which have to be resolved to identify the genetic hub related to this phenotype. Prompt diagnosis and early medical intervention would aid in minimizing the complications due to increased blood pressure. In an attempt to identify novel theragnostic (therapeutic and diagnostic) markers for EH, we turned our focus towards exosomes, which are extracellular vesicles derived from various cell types. Exosomes are found in almost all body fluids, such as saliva, breast milk, cerebrospinal fluid, and urine, and are thus a noninvasive source of biomarkers. These microvesicular bodies contain enormous information in the form of proteins and RNAs such as mRNAs, microRNAs (miRNAs) and other noncoding RNAs [3]. miRNAs are chromosomally encoded, small noncoding RNAs that can potentially influence the posttranscriptional process of target gene expression by regulating the translation of mRNA and maintenance of its stability in the cytoplasm. In addition, numerous studies have documented that miRNAs are associated with different forms of hypertension, including pulmonary hypertension. A recent report documents the emerging role of miRNAs in arterial fibrillation (AF) by reviewing the polymorphisms in miRNAs and correlating the observed variations with AF. As miRNAs play a significant role in heart development, any dysregulation in miRNA expression is linked to cardiac remodeling [4].

Consistent with this observation, the present study was designed to identify exosomal miRNAs in EH patients using computational tools. A recent study conducted by Ye et al. formed the basis for this research approach. The results of the study were quite promising and identified ~257 differentially expressed miRNAs in EH patients compared to control groups in the Uyghur population. These results were based on microarray data, which were further validated using quantitative real-time quantitative PCR (qRT-PCR). Among the 257 identified miRNAs, 47 were found to have target genes [5]. In the present study, each of these miRNAs was further queried against a list of 1424 miRNAs of different genera available in the ExoCarta database, including Homo sapiens [6]. Nearly 20 miRNAs from each group of upregulated and downregulated miRNAs were found to be located in the exosomes (Table 1). Although most of these exosomal miRNAs were associated with colorectal cancer cells, a few of the miRNAs were found to be derived from other sources, such as plasma, serum, B cells, T cells and dendritic cells.

Table 1 List of microRNAs upregulated and downregulated during EH found in the exosomes as analysed using ExoCarta
Full size table

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Arif M, Sadayappan S, Becker RC, Martin LJ, Urbina EM. Epigenetic modification: a regulatory mechanism in essential hypertension. Hypertens Res. 2019;42:1099–113.

    Article  CAS  Google Scholar 

  2. Salem H, Hasan DM, Eameash A, El-Mageed HA, Hasan S, Ali R. Worldwide prevalence of hypertension: a pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. J Am Coll Cardiol. 2018;71:1 [Supplement].

    Article  Google Scholar 

  3. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of Exosome Composition. Cell 2019;177:428–.e18.

    Article  CAS  Google Scholar 

  4. Komal S, Yin JJ, Wang SH, Huang CZ, Tao HL, Dong JZ, et al. MicroRNAs: emerging biomarkers for atrial fibrillation. J Cardiol. 2019; S0914-5087:30204–7.

  5. Ye Y, Yang J, Lv W, Lu Y, Zhang L, Zhang Y, et al. Screening of differentially expressed microRNAs of essential hypertension in Uyghur population. Lipids Health Dis. 2019;18:98.

    Article  Google Scholar 

  6. Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428:688–92.

    Article  CAS  Google Scholar 

  7. Zhao X, Yi Y, Meng C, Fang N. MiRNA-575 suppresses angiogenesis by targeting Rab5-MEK-ERK pathway in endothelial cells. Biosci Rep. 2019;39:BSR20181218.

    Article  Google Scholar 

  8. Assalin HB, Gontijo JAR, Boer PA. miRNAs, target genes expression and morphological analysis on the heart in gestational protein-restricted offspring. PLoS ONE. 2019;14:e0210454.

    Article  CAS  Google Scholar 

  9. Qi H, Liu Z, Liu B, Cao H, Sun W, Yan Y, et al. micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension. Med (Baltim). 2017;96:e6417.

    Article  CAS  Google Scholar 

  10. Solayman MH, Langaee T, Patel A, El-Wakeel L, El-Hamamsy M, Badary O, et al. Identification of suitable endogenous normalizers for qRT-PCR analysis of plasma microRNA expression in essential hypertension. Mol Biotechnol. 2016;58:179–87.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biomedical Research Unit and Laboratory Animal Centre-Dental Research Cell, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600077, India

    Vijayashree Priyadharsini Jayaseelan & Paramasivam Arumugam

Authors
  1. Vijayashree Priyadharsini Jayaseelan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paramasivam Arumugam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vijayashree Priyadharsini Jayaseelan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jayaseelan, V.P., Arumugam, P. Exosomal microRNAs as a promising theragnostic tool for essential hypertension. Hypertens Res 43, 74–75 (2020). https://doi.org/10.1038/s41440-019-0343-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-019-0343-2

This article is cited by

Search

Advanced search

Quick links